Abstract
For an ever-increasing number of species, the completed genomic sequence is available, providing a means to identify all the genes encoded in a genome. The functional relationships between these genes must be defined in order to generate a cohesive understanding of the molecular events that direct metazoan development. The model organism C. elegans, with its completed genomic sequence, defined cell lineage and robust genetics, provides an excellent opportunity to reconstruct the genetic relationships that underlie the development of a relatively simple animal. The change in expression of every predicted gene in the genome can be quantified under defined experimental conditions using DNA microarrays, thus providing a ”molecular signature“ of particular developmental processes. Because DNA microarray analysis does not rely upon detection of a gross morphological phenotype, genes whose function escapes identification in mutation screens can now be associated with different developmental processes. Together, C. elegans and DNA microarrays are a powerful combination with which to attack complex problems in developmental biology and work toward a more complete understanding of the underlying genetic networks governing development.
Keywords: Gene expression profiling, Functional genomics, clustering, microarrays
Current Genomics
Title: Defining Development Through Gene Expression Profiling
Volume: 3 Issue: 2
Author(s): Valerie Reinke
Affiliation:
Keywords: Gene expression profiling, Functional genomics, clustering, microarrays
Abstract: For an ever-increasing number of species, the completed genomic sequence is available, providing a means to identify all the genes encoded in a genome. The functional relationships between these genes must be defined in order to generate a cohesive understanding of the molecular events that direct metazoan development. The model organism C. elegans, with its completed genomic sequence, defined cell lineage and robust genetics, provides an excellent opportunity to reconstruct the genetic relationships that underlie the development of a relatively simple animal. The change in expression of every predicted gene in the genome can be quantified under defined experimental conditions using DNA microarrays, thus providing a ”molecular signature“ of particular developmental processes. Because DNA microarray analysis does not rely upon detection of a gross morphological phenotype, genes whose function escapes identification in mutation screens can now be associated with different developmental processes. Together, C. elegans and DNA microarrays are a powerful combination with which to attack complex problems in developmental biology and work toward a more complete understanding of the underlying genetic networks governing development.
Export Options
About this article
Cite this article as:
Reinke Valerie, Defining Development Through Gene Expression Profiling, Current Genomics 2002; 3 (2) . https://dx.doi.org/10.2174/1389202024605215
DOI https://dx.doi.org/10.2174/1389202024605215 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Immunity to Tumour Antigens
Current Pharmaceutical Design A New 4-phenyl-1,8-naphthyridine Derivative Affects Carcinoma Cell Proliferation by Impairing Cell Cycle Progression and Inducing Apoptosis
Anti-Cancer Agents in Medicinal Chemistry Distinctive Cellular Roles for Novel Protein Kinase C Isoenzymes
Current Pharmaceutical Design Anticancer Properties of the IL-12 Family - Focus on Colorectal Cancer
Current Medicinal Chemistry Recent Advances in Radiopharmaceutical Application of Matched-Pair Radiometals
Current Topics in Medicinal Chemistry Histopathology of Connective Tissue Disease-Associated Pleuropulmonary Disease
Current Respiratory Medicine Reviews Myokines in Myogenesis and Health
Recent Patents on Biotechnology HIV-1 Vpr: A Closer Look at the Multifunctional Protein from the Structural Perspective
Current HIV Research Isoform Characterisation, Heterologous Expression and Functional Analysis of Two Lectins from Vatairea macrocarpa
Protein & Peptide Letters Challenges in the Design of Clinically Useful Brain-targeted Drug Nanocarriers
Current Medicinal Chemistry Emerging Immunotargets in Bladder Cancer
Current Drug Targets Emerging RNA-based Drugs: siRNAs, microRNAs and Derivates
Central Nervous System Agents in Medicinal Chemistry The Interplay between G-quadruplex and Transcription
Current Medicinal Chemistry An Augmented Passive Immune Therapy to Treat Fulminant Bacterial Infections
Recent Patents on Anti-Infective Drug Discovery Long Term Prognosis in IgG4-Related Systemic Disease (ISD)
Current Immunology Reviews (Discontinued) Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections
Current Topics in Medicinal Chemistry Immune Dysfunction in Chronic Lymphocytic Leukemia: The Role for Immunotherapy
Current Pharmaceutical Design The Ubiquitin-Proteasome System and Proteasome Inhibitors in Central Nervous System Diseases
Cardiovascular & Hematological Disorders-Drug Targets Effect of Drugs in Cells and Tissues by NMR Spectroscopy
Current Topics in Medicinal Chemistry Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Biologically Active Agents
Current Medicinal Chemistry